miRNAs from multiple families have been identified to target CCNE1 in a number of malignant tumours, such as hepatocellular carcinoma [51], osteosarcoma [52], cervical cancer [53], and bladder cancer [54]. Here, CCNE1 is linked to urinary bladder cancer.